MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4251/wjgo.v9.i3.121

Медицинская библиотека · World journal of gastrointestinal oncology · 2017

Gastric peritoneal carcinomatosis - a retrospective review.

Tan Hwee Leong, Chia Claramae Shulyn, Tan Grace Hwei Ching, Choo Su Pin, Tai David Wai-Meng, Chua Clarinda Wei Ling, Ng Matthew Chau Hsien, Soo Khee Chee, Teo Melissa Ching Ching

СтатьяПеревод пока не подготовлен

Аннотация

AIM: To characterize patients with gastric peritoneal carcinomatosis (PC) and their typical clinical and treatment course with palliative systemic chemotherapy as the current standard of care.

METHODS

We performed a retrospective electronic chart review of all patients with gastric adenocarcinoma with PC diagnosed at initial metastatic presentation between January 2010 and December 2014 in a single tertiary referral centre.

RESULTS

We studied a total of 271 patients with a median age of 63.8 years and median follow-up duration of 5.1 mo. The majority (n = 217, 80.1%) had the peritoneum as the only site of metastasis at initial presentation. Palliative systemic chemotherapy was eventually planned for 175 (64.6%) of our patients at initial presentation, of which 171 were initiated on it. Choice of first-line regime was in accordance with the National Comprehensive Cancer Network Guidelines for Gastric Cancer Treatment. These patients underwent a median of one line of chemotherapy, completing a median of six cycles in total. Chemotherapy disruption due to unplanned hospitalizations occurred in 114 (66.7%), while cessation of chemotherapy occurred in 157 (91.8%), with 42 cessations primarily attributable to PC-related complications. Patients who had initiation of systemic chemotherapy had a significantly better median overall survival than those who did not (10.9 mo vs 1.6 mo, P < 0.001). Of patients who had initiation of systemic chemotherapy, those who experienced any disruptions to chemotherapy due to unplanned hospitalizations had a significantly worse median overall survival compared to those who did not (8.7 mo vs 14.6 mo, P < 0.001).

CONCLUSION

Gastric PC carries a grim prognosis with a clinical course fraught with disease-related complications which may attenuate any survival benefit which palliative systemic chemotherapy may have to offer. As such, investigational use of regional therapies is warranted and required validation in patients with isolated PC to maximize their survival outcomes in the long run.

Для цитирования: Tan Hwee Leong, Chia Claramae Shulyn, Tan Grace Hwei Ching, Choo Su Pin, Tai David Wai-Meng, Chua Clarinda Wei Ling, Ng Matthew Chau Hsien, Soo Khee Chee, Teo Melissa Ching Ching. Gastric peritoneal carcinomatosis - a retrospective review.. World journal of gastrointestinal oncology. 2017. DOI: 10.4251/wjgo.v9.i3.121.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.